Related Experiment Videos
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.
Annales de cardiologie et d'angeiologie·2021
Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.
European journal of gynaecological oncology·2018
Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
Current oncology (Toronto, Ont.)·2018
Surgical intervention in relapsed ovarian cancer is beneficial: contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Kratom at a crossroads: Trends, controversies, and the evidence gap.
Cleveland Clinic journal of medicine·2026
Navigating pulmonary nodules: Guidelines on assessing risk and determining next steps in primary care.
Cleveland Clinic journal of medicine·2026
Winning the battle against Barrett esophagus and esophageal adenocarcinoma.
Cleveland Clinic journal of medicine·2026
Treatment-refractory hypothyroidism: Don't just increase the dose.
Cleveland Clinic journal of medicine·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026